share_log
Benzinga ·  May 24, 2024 09:03
Cassava Sciences Receives Notice Of Allowance For US Patent Application Titled "Alzheimer's Disease Assay In A Living Patient" For Determining Likelihood Of Alzheimer's Disease Or Mild Cognitive Impairment Due To AD
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment